{Reference Type}: Journal Article
{Title}: Irreversible Electroporation as a Valid Treatment Option for Hepatic Epithelioid Hemangioendothelioma: An International Multicenter Experience.
{Author}: Narayanan G;Spano A;Gentile NT;Shnayder-Adams MM;Gurusamy V;Levi DM;Wilky BA;Mora RA;Noman R;Peddu P;Dijkstra M;
{Journal}: Cardiovasc Intervent Radiol
{Volume}: 47
{Issue}: 7
{Year}: 2024 Jul 6
{Factor}: 2.797
{DOI}: 10.1007/s00270-024-03770-5
{Abstract}: <B>OBJECTIVE: </B>Hepatic epithelioid hemangioendothelioma (HEHE) is a rare tumor with currently no established standard of care. This international multicenter retrospective study assesses the use of percutaneous irreversible electroporation (IRE) as an ablative tool to treat HEHE and provides a clinical overview of the current management and role of IRE in HEHE treatment.<BR><B>METHODS: </B>Between 2017 and 2023, 14 patients with 47 HEHE tumors were treated with percutaneous IRE using CT-scan guidance in 23 procedures. Baseline patient and tumor characteristics were evaluated. Primary outcome measures included safety and effectiveness, analyzed using Common Terminology Criteria for Adverse Events (CTCAE) and treatment response by mRECIST criteria. Secondary outcome measures included technical success, post-treatment tumor sizes and length of hospital stay. Technical success was defined as complete ablation with an adequate ablative margin (intentional tumor free ablation margin > 5 mm).<BR><B>RESULTS: </B>IRE treatment resulted in technical success in all tumors. Following a median follow-up of 15 months, 30 tumors demonstrated a complete response according to mRECIST criteria. The average tumor size pre-treatment was 25.8 mm, accompanied by an average reduction in tumor size by 7.5 mm. In 38 out of 47 tumors, there was no evidence of local recurrence. In nine tumors, residual tumor was present. There were no cases of progressive disease. Median length of hospital stay was one day. Only one grade 3 CTCAE event occurred, a pneumothorax requiring chest tube placement.<BR><B>CONCLUSIONS: </B>The current study provides evidence that IRE is a safe and efficacious minimally invasive treatment option for HEHE.